Search

Vaclav U Vetvicka

from Crestwood, KY
Age ~70

Vaclav Vetvicka Phones & Addresses

  • 1600 Abell Cir, Crestwood, KY 40014 (502) 493-8753
  • 3620 Brookhollow Dr, Louisville, KY 40220 (502) 493-8753 (502) 552-1502
  • 8501 Easton Commons Dr #8501, Louisville, KY 40242 (502) 426-4929 (502) 493-8753
  • Thornburg, IA
  • Lagrange, KY
  • 1600 Abell Cir, Crestwood, KY 40014 (502) 552-1502

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Resumes

Resumes

Vaclav Vetvicka Photo 1

Professor

View page
Location:
Louisville, KY
Industry:
Higher Education
Work:
University of Louisville
Professor
Education:
Charles University
Doctorates, Doctor of Philosophy, Biology
Skills:
Cancer Research
Cell Biology
Signal Transduction
Western Blotting
In Vivo
Chemistry
Animal Models
Confocal Microscopy
Biotechnology
Pcr
Cell
Immunology
Cell Culture
Scientific Writing
Molecular Biology
Immunohistochemistry
Bioinformatics
In Vitro
Cancer
Protein Expression
Research
Biochemistry
Science
Genetics
Flow Cytometry
Tissue Culture
Protein Chemistry
Stem Cells
Vaclav Vetvicka Photo 2

Professor At University Of Louisville

View page
Position:
Professor at University of Louisville
Location:
Louisville, Kentucky Area
Industry:
Writing and Editing
Work:
University of Louisville
Professor
Education:
Charles University in Prague
PhD, Biology
Skills:
Molecular Biology
Biotechnology
Biochemistry
Immunology
Western Blotting
Science
Cell Biology

Publications

Us Patents

Therapeutical Treatments

View page
US Patent:
6660722, Dec 9, 2003
Filed:
Nov 30, 2001
Appl. No.:
09/999202
Inventors:
Jean-Claude Yvin - Saint-Malo, FR
Vaclav Vetvicka - Louisville KY
Assignee:
Laboratoires Goemar S.A. - Saint-Malo
International Classification:
C08B 3718
US Classification:
514 54, 53612312, 5361231, 536124, 536122
Abstract:
Therapeutical method comprising administration to a patient of an effective amount of especially soluble laminarin for the treatment of tumors and more generally of cancers of the group comprising breast cancer, lung cancer, oesophagus cancer, stomach cancer, intestine and colon cancers, and for the treatment of viral, bacterial and fungal diseases as well as diseases related to immunostimulant deficiencies of human beings and warm-blood animals.

Therapeutical Combination Against Cancer

View page
US Patent:
7070778, Jul 4, 2006
Filed:
Oct 30, 2003
Appl. No.:
10/698034
Inventors:
Jean-Claude Yvin - Saint Malo, FR
Edouard Panak - Toulouse, FR
Vaclav Vetvicka - Louisville KY, US
Assignee:
Laboratoire Goemar SA - Saint-Malo
International Classification:
A61K 39/395
A61K 31/715
A01N 43/04
US Classification:
4241551, 4241431, 4241801, 4241811, 514 54, 514 61
Abstract:
The present invention relates to compositions and methods for treating humans and warm-blood animals suffering from cancer. More particularly, a therapeutical treatment in which a monoclonal antibody is administered with either β-(1,3)-glucan like laminarin or a oligo-β-(1,3)-glucan and a pharmaceutically acceptable carrier, to patients suffering from cancer are described.

Chemotherapeutic Antineoplastic Treatment

View page
US Patent:
7671040, Mar 2, 2010
Filed:
Sep 23, 2003
Appl. No.:
10/668661
Inventors:
Jean-Claude Yvin - Saint Malo, FR
Vaclav Vetvicka - Louisville KY, US
Assignee:
Laboratoires Goemar S.A. - Saint-Malo
International Classification:
A61K 31/715
A61K 31/716
C08B 37/18
US Classification:
514 54, 53612312, 5361231, 536124
Abstract:
Chemotherapeutic antineoplastic method comprising administration of an effective amount of an antineoplastic agent in conjunction with an effective amount of a β-1,3 glucan.

Therapeutical Treatment With Oligo-Beta- (1,3) -Glucans, Drugs Used In Said Treatment

View page
US Patent:
20050065114, Mar 24, 2005
Filed:
Sep 23, 2003
Appl. No.:
10/668665
Inventors:
Jean-Claude Yvin - Saint Malo, FR
Frank Jamois - La Chapelle Des Fougeretz, FR
Vaclav Vetvicka - Louisville KY, US
International Classification:
A61K031/715
US Classification:
514061000
Abstract:
A therapeutical method comprising administration of a composition comprising an amount of oligo-β-(1,3)-glucan and a pharmaceutically acceptable carrier, to a human being or to a warm-blood animal suffering from a disease selected from the group consisting in a tumor, a cancer, a viral disease, a bacterial disease, a fungal disease, a disease of the immune system, an auto-immune disease or a disease related to a deficiency of immunostimulation, wherein the amount of oligo-β-(1,3)-glucan is effective to treat the disease.

Systems And Methods For Diagnosis And Prognosis Of Cancer

View page
US Patent:
20110081669, Apr 7, 2011
Filed:
Jun 16, 2009
Appl. No.:
12/999389
Inventors:
Vaclav Vetvicka - Louisville KY, US
Martin Fusek - Tursko, CZ
Jarmila Zidkova - Prague, CZ
Assignee:
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. - Louisville KY
International Classification:
G01N 33/53
C12M 1/34
US Classification:
435 792, 4352872
Abstract:
Methods for diagnosing a cancer in a subject are provided that include determining an amount of autoantibodies immunoreactive to procathepsin D (pCD) in a sample obtained from the subject. Further provided are systems for diagnosing a cancer in a subject that include an autoantibody immunoreactive pCD antigen and a means for detecting binding of an autoantibody to the antigen.

Use Of Modified Oligo-B-(1,3)-Glucanes For Treating Diseases Of The Immune System Oligo-B-(1,3V-Glucane-(1,3)-Mannose, Oligo-B-(1,3)-Glucane-(1,3)-Mannitol And Derivatives Thereof, Methods For Preparing The Same And Drugs Containing Them

View page
US Patent:
20130178616, Jul 11, 2013
Filed:
Nov 19, 2012
Appl. No.:
13/681132
Inventors:
ASE & BIO. - Paris, FR
Karine DESCROIX - Saint-colomban, FR
Vincent FERRIERES - Gahard, FR
Frank JAMOIS - La Chapelle Des Fouegeretz, FR
Isabelle LAURENT - Rennes, FR
Vaclav VETVICKA - Louisville KY, US
Assignee:
ASE & BIO. - Paris
International Classification:
C07H 3/06
US Classification:
5361231
Abstract:
The present invention relates to the use of at least one compound of formula (III), (IV), (V) or (VI), in which p is an integer from 0 to 9; and R2 represents hydrogen, allyl, methylnaphthyl, benzyl, paramethoxybenzyl, or halogenoacetyl, for the preparation of a medicament for treating diseases such as tumors, cancer, viral disease, bacterial disease, fungal disease, disease of the immune system, auto-immune disease or disease linked to a deficiency in immunostimulation, in human beings and warm-blooded animals. The invention also relates to new products having a mannose or mannitol termination as well as a method for preparing them.

Method For Inhibition Of Breast Tumor Growth

View page
US Patent:
58008144, Sep 1, 1998
Filed:
Apr 22, 1994
Appl. No.:
8/232997
Inventors:
Martin Fusek - Oklahoma City OK
Vaclav Vetvicka - Louisville KY
Assignee:
Oklahoma Medical Research Foundation - Oklahoma City OK
International Classification:
A61K 39395
A61K 3800
US Classification:
4241331
Abstract:
Human procathepsin D was demonstrated to be mitogenic for breast cancer cells but not normal cells. The activation peptide of the procathepsin D appears to be responsible, since inhibition of enhancement of proliferation of breast cancer cells can be obtained by inhibition of the activation peptide through the use of an agent such as an antibody immunoreactive with the activation peptide.

Isbn (Books And Publications)

Methods in Cellular Immunology

View page
Author

Vaclav Vetvicka

ISBN #

0849309220

Advanced Methods in Cellular Immunology

View page
Author

Vaclav Vetvicka

ISBN #

0849321255

Immunology of Annelids

View page
Author

Vaclav Vetvicka

ISBN #

0849349095

Immune System Accessory Cells

View page
Author

Vaclav Vetvicka

ISBN #

0849359821

Evolution of Immune Reactions

View page
Author

Vaclav Vetvicka

ISBN #

0849365937

Methods in Cellular Immunology

View page
Author

Vaclav Vetvicka

ISBN #

0849365481

Aspartic Proteinases: Physiology and Pathology

View page
Author

Vaclav Vetvicka

ISBN #

0849376602

Vaclav U Vetvicka from Crestwood, KY, age ~70 Get Report